Corentin Orvain
About
Corentin Orvain is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Corentin Orvain has authored 59 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 23 papers in Genetics and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Corentin Orvain's work include Acute Myeloid Leukemia Research (30 papers), Hematopoietic Stem Cell Transplantation (21 papers) and Acute Lymphoblastic Leukemia research (15 papers). Corentin Orvain is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Hematopoietic Stem Cell Transplantation (21 papers) and Acute Lymphoblastic Leukemia research (15 papers). Corentin Orvain collaborates with scholars based in France, United States and Spain. Corentin Orvain's co-authors include Mathilde Hunault, Aline Schmidt, Jean‐François Augusto, Roland B. Walter, Megan Othus, Damien Luque Paz, Brenda M. Sandmaier, Valérie Ugo, Sylvie François and Jérémie Riou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Transplantation.
In The Last Decade
Corentin Orvain
51 papers receiving 379 citations
Peers
Corentin Orvain
Fotios Panitsas Greece
Ana‐Maria Vlădăreanu Romania
Michele Pizzuti Italy
José Miguel Couselo Spain
Isabel Sanjuán Spain
Masa Lasica Australia
Ozan Salim Türkiye
J R Schriber United States
Ihab El‐Hemaidi Saudi Arabia
Madelyn Burkart United States
Citations per year, relative to Corentin Orvain Corentin Orvain (= 1×)
peers
Fotios Panitsas
Countries citing papers authored by Corentin Orvain
Since
Specialization
Citations
This map shows the geographic impact of Corentin Orvain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corentin Orvain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corentin Orvain more than expected).
Fields of papers citing papers by Corentin Orvain
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Corentin Orvain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corentin Orvain. The network helps show where Corentin Orvain may publish in the future.
Co-authorship network of co-authors of Corentin Orvain
This figure shows the co-authorship network connecting the top 25 collaborators of Corentin Orvain. A scholar is included among the top collaborators of Corentin Orvain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corentin Orvain. Corentin Orvain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Curis, Emmanuel, Marie‐Hélène Schlageter, Nelly Bosselut, et al.. (2025). Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis. Cancer Immunology Immunotherapy. 74(6). 181–181.
2.
Orvain, Corentin, Megan Othus, Eduardo Rodríguez‐Arbolí, et al.. (2024). Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS /AML or AML . American Journal of Hematology. 99(5). 862–870.
3.
Othus, Megan, Eduardo Rodríguez‐Arbolí, Corentin Orvain, et al.. (2024). Relationship between morphologic remission with or without hematologic recovery and outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia. Bone Marrow Transplantation. 59(12). 1667–1675.
4.
Othus, Megan, Eduardo Rodríguez‐Arbolí, Corentin Orvain, et al.. (2024). Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML. Blood Advances. 9(3). 558–570.
5.
Paz, Damien Luque, Corentin Orvain, Jean‐Christophe Ianotto, et al.. (2024). Dynamics of Calrvariant Allele Frequency with Therapy in Myeloproliferative Neoplasms. Blood. 144(Supplement 1). 485–485.
6.
Bouvier, Anne, Jérémie Riou, Sylvain Thépot, et al.. (2023). Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores. American Journal of Hematology. 98(6). 922–931.
7.
Wiedemann, Arnaud, Jean‐Hugues Dalle, Karin Bilger, et al.. (2023). Efficacy of haematopoietic stem cell boost as a rescue for poor graft function after haematopoietic stem cell transplantation: A multicentre retrospective study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM‐TC ). British Journal of Haematology. 201(6). 1153–1158.
8.
Garciaz, Sylvain, Sarah Bertoli, David A. Sallman, et al.. (2023). Acute Myeloid Leukemia Patients Who Stopped Venetoclax or/and Azacytidine for Other Reasons Than Progression Have a Prolonged Treatment Free Remission and Overall Survival. a Filo Study. Blood. 142(Supplement 1). 161–161.
9.
Othus, Megan, Corentin Orvain, Eduardo Rodríguez‐Arbolí, et al.. (2023). Impact of Socioeconomic Disparities on Outcomes in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia. Blood. 142(Supplement 1). 3809–3809.
10.
Riou, Jérémie, Pierre Péterlin, Tony Marchand, et al.. (2022). Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia—a Grand Ouest Against Leukemia (GOAL) study. Leukemia. 36(10). 2408–2417.
11.
Schmidt, Aline, Achille Kouatchet, Valérie Moal, et al.. (2022). Serum phosphate level and its kinetic as an early marker of acute kidney injury in tumor lysis syndrome. Journal of Nephrology. 35(6). 1627–1636.
12.
Orvain, Corentin, Min Fang, Brenda M. Sandmaier, et al.. (2022). Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia. Haematologica. 108(2). 420–432.
13.
Orvain, Corentin, Jean‐Christophe Ianotto, Valérie Ugo, et al.. (2021). Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis. Blood Cancer Journal. 11(7). 135–135.
14.
Mageau, Arthur, Louis Terriou, Mikaël Ebbo, et al.. (2021). Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment. American Journal of Hematology. 97(1). 10–17.
15.
Fage, Nicolas, Corentin Orvain, Nicolás Henry, et al.. (2021). Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy Syndrome. Kidney International Reports. 7(2). 221–231.
16.
Bouvier, Anne, Jérémie Riou, Sylvain Thépot, et al.. (2019). Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation. Leukemia. 34(5). 1342–1353.
17.
Orvain, Corentin, Philippe Joly, Serge Pissard, et al.. (2017). Diagnostic approach to hemoglobins with high oxygen affinity: experience from France and Belgium and review of the literature. Annales de biologie clinique. 75(1). 39–51.
18.
Orvain, Corentin, Damien Luque Paz, Irène Dobo, et al.. (2016). Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study. Annals of Hematology. 95(11). 1819–1823.
19.
Orvain, Corentin, François Beloncle, Jean‐François Hamel, et al.. (2016). Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care. Transplantation. 101(2). 437–444.
20.
Orvain, Corentin, Jean‐François Augusto, Marc Guillaume, et al.. (2013). Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis. International Urology and Nephrology. 46(1). 239–242.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fotios Panitsas Breakdown of academic impact, for papers by Ana‐Maria Vlădăreanu Breakdown of academic impact, for papers by Michele Pizzuti Breakdown of academic impact, for papers by José Miguel Couselo Breakdown of academic impact, for papers by Isabel Sanjuán Breakdown of academic impact, for papers by Masa Lasica Breakdown of academic impact, for papers by Ozan Salim Breakdown of academic impact, for papers by J R Schriber Breakdown of academic impact, for papers by Ihab El‐Hemaidi Breakdown of academic impact, for papers by Madelyn Burkart